For the third year in a row, Genome Medical has been named a CB Insights Digital Health 150 company. The 2021 Digital Health 150 cohort comprises a broad range of health care startups, business partnerships among key industry players, and promising private digital health companies that are transforming the future of health care.
As a leading virtual provider of genomic medicine, Genome Medical is bringing genomic health care to everyone through technology and care delivery innovation. We make genomic medicine more accessible and cost-effective and help integrate genetics into routine medical care.
"We are on a mission to give people the power to personalize their health by moving providers and patients toward genome-centered health care," said Lisa Alderson, Genome Medical CEO and co-founder. "This year, we raised an additional $60 million in capital in our Series C financing led by Casdin Capital, brought in new investors including GV and Amgen Ventures, and acquired the genetic counseling company GeneMatters. We have the talent and assets we need to grow exponentially in 2022 and beyond."
The CB Insights research team selected the Digital Health 150 from a pool of more than 11,000 companies through an evidence-based approach, including applicants and nominees. The companies were chosen based on several factors, including momentum in the market and Mosaic scores, CB Insights' proprietary algorithm that measures private companies' overall health and growth potential.
Investment highlights from the 2021 Digital Health 150 include:
- Unicorns: 11% of the companies are valued at or above $1 billion as of their latest funding rounds.
- Funding trends: In 2021, these 150 private companies have raised $9.2 billion in equity funding across 153 deals (as of Nov. 11, 2021).
- Mega-rounds: Since 2020, there have been 39 mega-round equity investments ($100 million-plus) to this year's Digital Health 150, with 79% of them taking place in 2021.
- This year's winners are based in 18 countries, including China, Israel, Nigeria, Germany, Argentina and New Zealand.
- Top venture capital investor: General Catalyst is the most active investor in this year's Digital Health 150 companies, having invested in 39 deals since 2016.
"This year's Digital Health 150 is one of our most expansive yet, spotlighting 16 categories including virtual care, clinical trials tech, and workflow automation, as well as adding new categories such as home health tech and computer-aided imaging," said Brian Lee, SVP of CB Insights' Intelligence Unit. "Last year's class has seen more than 20 exits, raised an additional $18.6 billion in aggregate funding, and announced over 250 partnerships since being recognized, and we're excited to see the future success of this year's winners."
To learn more about the companies that are innovating the new digital health care landscape, visit CB Insights Digital Health 150 here.